# Haw Par Healthcare Limited - Inspection Records

Source: https://www.keypedia.com/companies/haw-par-healthcare-limited/4624588e-3f62-4c4c-8ea2-297ba6465337

> Inspection records and compliance data for Haw Par Healthcare Limited in Singapore, None. Access full analysis and detailed observations.

---

## Details

- Name: Haw Par Healthcare Limited
- FEI Number: 3001432470
- City: Singapore
- State: None
- Country Name: Singapore
- Address Line 1: 2 Chia Ping Road, #09-03 Haw Par Tiger Balm Building
- Zip Code: None

## Related Documents

- [483 - Haw Par Healthcare Limited - 2024-09-27](https://www.keypedia.com/records/483/haw-par-healthcare-limited/c7dcad3f-f3a2-4d86-878d-3679cc6ad271) — source: FDA, date: September 27, 2024
- [483 - Haw Par Healthcare Limited - 2024-09-27](https://www.keypedia.com/records/483/haw-par-healthcare-limited/4dac1d33-1f68-478e-8029-a1ef095208cc) — source: FDA, date: September 27, 2024
- [FDA Inspection 1250188 - Haw Par Healthcare Limited - 2024-09-27](https://www.keypedia.com/records/fda_inspections/haw-par-healthcare-limited/f16ba831-da4c-42d2-82c1-0e95993cc687) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 27, 2024
- [483 - Haw Par Healthcare Limited - 2022-08-19](https://www.keypedia.com/records/483/haw-par-healthcare-limited/19fa39fa-eb0b-4a0d-9906-a57810ecacf5) — source: FDA, date: August 19, 2022
- [FDA Inspection 1177852 - Haw Par Healthcare Limited - 2022-08-19](https://www.keypedia.com/records/fda_inspections/haw-par-healthcare-limited/0d1247d8-8338-4bbc-abb0-aefa098ba972) — classification: Official Action Indicated (OAI), source: FDA, date: August 19, 2022
- [483 - Haw Par Healthcare Limited - 2019-03-01](https://www.keypedia.com/records/483/haw-par-healthcare-limited/3258265a-6763-438b-a9d4-ac8272b13205) — source: FDA, date: March 1, 2019
- [WARNING_LETTER - Haw Par Healthcare Limited - 2019-03-01](https://www.keypedia.com/records/warning_letter/haw-par-healthcare-limited/094105c2-2599-4ab6-85e7-914f80d45d3c) — source: FDA, date: March 1, 2019
- [FDA Inspection 1080852 - Haw Par Healthcare Limited - 2019-03-01](https://www.keypedia.com/records/fda_inspections/haw-par-healthcare-limited/e690d782-dc95-4d3c-8025-81b940da584e) — classification: Official Action Indicated (OAI), source: FDA, date: March 1, 2019
- [FDA Inspection 974315 - Haw Par Healthcare Limited - 2016-05-26](https://www.keypedia.com/records/fda_inspections/haw-par-healthcare-limited/4dbfc50e-d93c-4c99-baf1-27eddc91771b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 26, 2016
- [FDA Inspection 873440 - Haw Par Healthcare Limited - 2014-03-28](https://www.keypedia.com/records/fda_inspections/haw-par-healthcare-limited/a4929fc6-5c8a-4c1e-a677-237a11dd9819) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 28, 2014
- [FDA Inspection 633558 - Haw Par Healthcare Limited - 2009-10-29](https://www.keypedia.com/records/fda_inspections/haw-par-healthcare-limited/0868288e-1978-462d-8ec7-92c5d59d5a15) — classification: Official Action Indicated (OAI), source: FDA, date: October 29, 2009
- [FDA Inspection 633558 - Haw Par Healthcare Limited - 2009-10-29](https://www.keypedia.com/records/fda_inspections/haw-par-healthcare-limited/7b7ca086-6d67-4ea3-aa47-70f71a929070) — classification: Official Action Indicated (OAI), source: FDA, date: October 29, 2009

## Related Companies

- [Gemini Pharmaceuticals, Inc.](https://www.keypedia.com/companies/gemini-pharmaceuticals-inc/9e83f65c-3863-4ad6-a434-b37d9673ac0f)
- [Chemco Corporation](https://www.keypedia.com/companies/chemco-corporation/916d88f7-9782-4797-80cc-bcadd0c8915a)
- [Spartan Chemical Co Inc](https://www.keypedia.com/companies/spartan-chemical-co-inc/96e5b21e-5d00-402a-a2ce-3c38c571a9b9)
- [MEDGEL PRIVATE LIMITED](https://www.keypedia.com/companies/medgel-private-limited/726df899-b5d3-4a4d-b97b-0abe34dc7ea3)
- [SOFIE Co](https://www.keypedia.com/companies/sofie-co/d06f8036-2bc5-4dbb-885b-341a1ecbb82a)
- [Avadim Holdings Inc](https://www.keypedia.com/companies/avadim-holdings-inc/6dc31a43-08a1-4771-8f42-d6cca75dbc5b)
- [ADMA Biologics, Inc](https://www.keypedia.com/companies/adma-biologics-inc/dcb996fb-4a71-44fe-87f1-cfe3979d4182)
- [Gadal Laboratories Inc.](https://www.keypedia.com/companies/gadal-laboratories-inc/ab020b2d-bc0c-4731-bc27-f75fc34163d4)
- [Transpire Bio Inc.](https://www.keypedia.com/companies/transpire-bio-inc/f2ab3def-2519-4172-8194-14a7f372db87)
- [Hankook Cosmetics Manufacturing Co., Ltd](https://www.keypedia.com/companies/hankook-cosmetics-manufacturing-co-ltd/bad91ffc-3949-43ef-a17a-592af478eebd)

## Related Officers

- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Director](https://www.keypedia.com/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)
- [Jennifer L. Huntington](https://www.keypedia.com/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)